Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2014 Filed Mar 4, 2014 22:04 UTC |
Warmuth Michael JExecutive Vice President
|
SaleCommon shares without par value | 1,700 | $38.97 | $66,250.70 |
DisclosureSEC source: 0001179110-14-004299 · edgar.xml · nonDerivative · entry 2 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,635 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:05 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 600 | $39.38 | $23,630.40 |
DisclosureSEC source: 0001179110-14-004301 · edgar.xml · nonDerivative · entry 5 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,136 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:05 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 2,000 | $39.38 | $78,762.00 |
DisclosureSEC source: 0001179110-14-004301 · edgar.xml · nonDerivative · entry 4 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,736 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:05 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 650 | $39.37 | $25,590.50 |
DisclosureSEC source: 0001179110-14-004301 · edgar.xml · nonDerivative · entry 3 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,736 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:05 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 4,831 | $39.37 | $190,177.15 |
DisclosureSEC source: 0001179110-14-004301 · edgar.xml · nonDerivative · entry 2 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,386 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:05 UTC |
FREYMAN THOMAS CExecutive Vice President
|
SaleCommon shares without par value | 2,984 | $39.10 | $116,686.34 |
DisclosureSEC source: 0001179110-14-004303 · edgar.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,326 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:05 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
SaleCommon shares without par value | 700 | $38.97 | $27,281.80 |
DisclosureSEC source: 0001179110-14-004305 · edgar.xml · nonDerivative · entry 3 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,926 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:05 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
SaleCommon shares without par value | 713 | $38.97 | $27,786.32 |
DisclosureSEC source: 0001179110-14-004305 · edgar.xml · nonDerivative · entry 2 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,626 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:06 UTC |
ALLEN HUBERT LExecutive Vice President
|
SaleCommon shares without par value | 1,543 | $39.03 | $60,229.46 |
DisclosureSEC source: 0001179110-14-004307 · edgar.xml · nonDerivative · entry 2 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,525 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:06 UTC |
Foltz Charles DSenior Vice President
|
SaleCommon shares without par value | 1,588 | $38.95 | $61,854.19 |
DisclosureSEC source: 0001179110-14-004308 · edgar.xml · nonDerivative · entry 2 Foltz Charles D · CIK 0001573318 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,318 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:06 UTC |
ASHLEY RICHARD WExecutive Vice President
|
SaleCommon shares without par value | 1,600 | $39.00 | $62,406.40 |
DisclosureSEC source: 0001179110-14-004309 · edgar.xml · nonDerivative · entry 3 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,072 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:06 UTC |
ASHLEY RICHARD WExecutive Vice President
|
SaleCommon shares without par value | 498 | $39.00 | $19,423.00 |
DisclosureSEC source: 0001179110-14-004309 · edgar.xml · nonDerivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,672 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:07 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 1,441 | $39.01 | $56,219.17 |
DisclosureSEC source: 0001179110-14-004310 · edgar.xml · nonDerivative · entry 2 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,895 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:07 UTC |
Mason Heather LSenior Vice President
|
SaleCommon shares without par value | 1,096 | $38.95 | $42,690.30 |
DisclosureSEC source: 0001179110-14-004312 · edgar.xml · nonDerivative · entry 3 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,410 Read SEC document |
| March 03, 2014 Filed Mar 4, 2014 22:07 UTC |
Mason Heather LSenior Vice President
|
SaleCommon shares without par value | 1,100 | $38.95 | $42,849.40 |
DisclosureSEC source: 0001179110-14-004312 · edgar.xml · nonDerivative · entry 2 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,506 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 91,882 | $39.79 | $3,655,984.78 |
DisclosureSEC source: 0001179110-14-004293 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,414,525 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:04 UTC |
Landgraf John CExecutive Vice President
|
Tax withholdingCommon shares without par value | 15,307 | $39.79 | $609,065.53 |
DisclosureSEC source: 0001179110-14-004294 · edgar.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,424 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:04 UTC |
Doyle Katherine C.Senior Vice President
|
Tax withholdingCommon shares without par value | 4,043 | $39.79 | $160,870.97 |
DisclosureSEC source: 0001179110-14-004297 · edgar.xml · nonDerivative · entry 1 Doyle Katherine C. · CIK 0001570003 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,164 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:04 UTC |
Warmuth Michael JExecutive Vice President
|
Tax withholdingCommon shares without par value | 8,152 | $39.79 | $324,368.08 |
DisclosureSEC source: 0001179110-14-004299 · edgar.xml · nonDerivative · entry 1 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,335 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:05 UTC |
Contreras JaimeSenior Vice President
|
Tax withholdingCommon shares without par value | 3,919 | $39.79 | $155,937.01 |
DisclosureSEC source: 0001179110-14-004301 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,217 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:05 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 27,660 | $39.79 | $1,100,591.40 |
DisclosureSEC source: 0001179110-14-004303 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,310 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:05 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
Tax withholdingCommon shares without par value | 3,129 | $39.79 | $124,502.91 |
DisclosureSEC source: 0001179110-14-004305 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,339 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:06 UTC |
Fussell Stephen RExecutive Vice President
|
Tax withholdingCommon shares without par value | 13,414 | $39.79 | $533,743.06 |
DisclosureSEC source: 0001179110-14-004306 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,764 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:06 UTC |
ALLEN HUBERT LExecutive Vice President
|
Tax withholdingCommon shares without par value | 4,572 | $39.79 | $181,919.88 |
DisclosureSEC source: 0001179110-14-004307 · edgar.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,068 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:06 UTC |
Foltz Charles DSenior Vice President
|
Tax withholdingCommon shares without par value | 4,086 | $39.79 | $162,581.94 |
DisclosureSEC source: 0001179110-14-004308 · edgar.xml · nonDerivative · entry 1 Foltz Charles D · CIK 0001573318 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,906 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:06 UTC |
ASHLEY RICHARD WExecutive Vice President
|
Tax withholdingCommon shares without par value | 22,004 | $39.79 | $875,539.16 |
DisclosureSEC source: 0001179110-14-004309 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,170 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:07 UTC |
Blaser Brian J.Executive Vice President
|
Tax withholdingCommon shares without par value | 13,097 | $39.79 | $521,129.63 |
DisclosureSEC source: 0001179110-14-004310 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,336 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:07 UTC |
CAPEK JOHN MExecutive Vice President
|
Tax withholdingCommon shares without par value | 13,263 | $39.79 | $527,734.77 |
DisclosureSEC source: 0001179110-14-004313 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,945 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:07 UTC |
Mason Heather LSenior Vice President
|
Tax withholdingCommon shares without par value | 9,800 | $39.79 | $389,942.00 |
DisclosureSEC source: 0001179110-14-004312 · edgar.xml · nonDerivative · entry 1 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,606 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:10 UTC |
Simhambhatla Murthy VSenior Vice President
|
Tax withholdingCommon shares without par value | 2,882 | $39.79 | $114,674.78 |
DisclosureSEC source: 0001179110-14-004319 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,865 Read SEC document |
| February 28, 2014 Filed Mar 4, 2014 22:10 UTC |
White J. ScottSenior Vice President
|
Tax withholdingCommon shares without par value | 10,477 | $39.79 | $416,879.83 |
DisclosureSEC source: 0001179110-14-004323 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,566 Read SEC document |
| February 28, 2014 Filed Mar 7, 2014 22:01 UTC Amendment |
Warmuth Michael JExecutive Vice President
|
GrantCommon shares without par value | 29,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-004751 · edgar.xml · nonDerivative · entry 1 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,184 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:04 UTC |
Doyle Katherine C.Senior Vice President
|
GrantOption (right to buy) · Derivative | 87,061 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003603 · edgar.xml · derivative · entry 2 Doyle Katherine C. · CIK 0001570003 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,061 Underlying: Common shares · 87,061 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 29,021 on 2/21/2015, 29,020 on 2/21/2016, and 29,020 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:04 UTC |
Doyle Katherine C.Senior Vice President
|
GrantCommon shares without par value | 14,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003603 · edgar.xml · nonDerivative · entry 1 Doyle Katherine C. · CIK 0001570003 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,207 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:05 UTC |
Mason Heather LSenior Vice President
|
GrantOption (right to buy) · Derivative | 110,107 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003607 · edgar.xml · derivative · entry 2 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,107 Underlying: Common shares · 110,107 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 36,703 on 2/21/2015, 36,702 on 2/21/2016, and 36,702 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:05 UTC |
Mason Heather LSenior Vice President
|
GrantCommon shares without par value | 17,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003607 · edgar.xml · nonDerivative · entry 1 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,406 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:04 UTC |
Foltz Charles DSenior Vice President
|
GrantOption (right to buy) · Derivative | 102,425 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003605 · edgar.xml · derivative · entry 2 Foltz Charles D · CIK 0001573318 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,425 Underlying: Common shares · 102,425 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 34,142 on 2/21/2015, 34,141 on 2/21/2016, and 34,142 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:04 UTC |
Foltz Charles DSenior Vice President
|
GrantCommon shares without par value | 16,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003605 · edgar.xml · nonDerivative · entry 1 Foltz Charles D · CIK 0001573318 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,992 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:06 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 200,477 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003608 · edgar.xml · derivative · entry 8 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,477 Underlying: Common shares · 200,477 shares Expires 2024-02-20 F7 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 66,826 on 2/21/2015, 66,825 on 2/21/2016, and 66,826 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:06 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantCommon shares without par value | 32,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003608 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,970 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:07 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantOption (right to buy) · Derivative | 134,741 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003612 · edgar.xml · derivative · entry 2 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,741 Underlying: Common shares · 134,741 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 44,914 on 2/21/2015, 44,913 on 2/21/2016, and 44,914 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:07 UTC |
ASHLEY RICHARD WExecutive Vice President
|
GrantCommon shares without par value | 22,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003612 · edgar.xml · nonDerivative · entry 1 ASHLEY RICHARD W · CIK 0001278570 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,174 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:08 UTC |
ALLEN HUBERT LExecutive Vice President
|
GrantOption (right to buy) · Derivative | 107,793 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003615 · edgar.xml · derivative · entry 2 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,793 Underlying: Common shares · 107,793 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 35,931 on 2/21/15, 35,931 on 2/21/16, and 35,931 on 2/21/17. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:08 UTC |
ALLEN HUBERT LExecutive Vice President
|
GrantCommon shares without par value | 17,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003615 · edgar.xml · nonDerivative · entry 1 ALLEN HUBERT L · CIK 0001565916 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,640 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:09 UTC |
Blaser Brian J.Executive Vice President
|
GrantOption (right to buy) · Derivative | 175,164 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003618 · edgar.xml · derivative · entry 2 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,164 Underlying: Common shares · 175,164 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 58,388 on 2/21/2015, 58,388 on 2/21/2016, and 58,388 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:09 UTC |
Blaser Brian J.Executive Vice President
|
GrantCommon shares without par value | 28,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003618 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,433 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:09 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantOption (right to buy) · Derivative | 141,478 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003619 · edgar.xml · derivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,478 Underlying: Common shares · 141,478 shares Expires 2024-02-20 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 47,160 on 2/21/2015, 47,159 on 2/21/2016, and 47,159 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:09 UTC |
CAPEK JOHN MExecutive Vice President
|
GrantCommon shares without par value | 23,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003619 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,208 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:12 UTC |
Contreras JaimeSenior Vice President
|
GrantOption(right to buy) · Derivative | 112,668 | $0.00 Strike: $39.12 | $0.00 |
DisclosureSEC source: 0001179110-14-003623 · edgar.xml · derivative · entry 7 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,668 Underlying: Common shares · 112,668 shares Expires 2024-02-20 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 37,556 on 2/21/2015, 37,556 on 2/21/2016, and 37,556 on 2/21/2017. Read SEC document |
| February 21, 2014 Filed Feb 25, 2014 22:12 UTC |
Contreras JaimeSenior Vice President
|
GrantCommon shares without par value | 18,403 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-003623 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,136 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.